MarketBeat Instant News Alerts 2 hours agoUnicycive Therapeutics (NASDAQ:UNCY) Stock Price Down 1.3% - Should You Sell?MarketBeatUnicycive Therapeutics (NASDAQ:UNCY) Stock Falls 1.3% - Time to Sell?NASDAQ:UNCYRead Unicycive Therapeutics (NASDAQ:UNCY) Stock Price Down 1.3% - Should You Sell?2 hours agoTwelve Seas Investment Company II (NASDAQ:TWLV) Shares Climb 0.2% - Here's WhyMarketBeatTwelve Seas Investment Company II (NASDAQ:TWLV) Shares Up 0.2% - Should You Buy?NASDAQ:TWLVRead Twelve Seas Investment Company II (NASDAQ:TWLV) Shares Climb 0.2% - Here's Why2 hours agoTrustpilot Group (LON:TRST) Stock Price Down 4.2% - Time to Sell?MarketBeatTrustpilot Group (LON:TRST) Stock Falls 4.2% - Here's What HappenedLON:TRSTRead Trustpilot Group (LON:TRST) Stock Price Down 4.2% - Time to Sell?2 hours agoChargePoint (NYSE:CHPT) Stock Jumps 1.8% - What's Next?MarketBeatChargePoint (NYSE:CHPT) Shares Up 1.8% - Here's WhyNYSE:CHPTRead ChargePoint (NYSE:CHPT) Stock Jumps 1.8% - What's Next?2 hours agoAlto Ingredients (NASDAQ:ALTO) Shares Climb 0.6% - Should You Buy?MarketBeatAlto Ingredients (NASDAQ:ALTO) Stock Jumps 0.6% - Here's WhyNASDAQ:ALTORead Alto Ingredients (NASDAQ:ALTO) Shares Climb 0.6% - Should You Buy?2 hours agoEaton Vance California Municipal Income Trust (NYSE:CEV) Shares Down 0.6% - Time to Sell?MarketBeatEaton Vance California Municipal Income Trust (NYSE:CEV) Shares Down 0.6% - What's Next?NYSE:CEVRead Eaton Vance California Municipal Income Trust (NYSE:CEV) Shares Down 0.6% - Time to Sell? Trending News1Cerebras Systems (NASDAQ:CBRS) Stock Falls 2% Following Analyst Downgrade2Cerebras Systems (NASDAQ:CBRS) Stock Price Down 5.1% - Should You Sell?3Archer Aviation Inc. (NYSE:ACHR) Stock Has Consensus Price Target of $11.004BigBear.ai (BBAI) Projected to Release Earnings on Tuesday5Cerebras Systems Inc. $CBRS Stock Position Increased by ICG Advisors LLC6USA Rare Earth (NASDAQ:USAR) Stock Falls 4.3% - Time to Sell?7Advanced Micro Devices (NASDAQ:AMD) Stock Gets Price Target Boost from Susquehanna8What SpaceX (SPCX) Said on Its Q3 Earnings Call All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords More filters Fewer filters Done 2 hours agoARKO (NASDAQ:ARKO) Shares Down 6.8% - Time to Sell?MarketBeatNASDAQ:ARKORead ARKO (NASDAQ:ARKO) Shares Down 6.8% - Time to Sell?2 hours agoGreenwich LifeSciences (NASDAQ:GLSI) Shares Climb 3.6% - Time to Buy?MarketBeatNASDAQ:GLSIRead Greenwich LifeSciences (NASDAQ:GLSI) Shares Climb 3.6% - Time to Buy?2 hours agoNuveen Select Maturities Municipal Fund (NYSE:NIM) Stock Falls 0.6% - Should You Sell?MarketBeatNYSE:NIMRead Nuveen Select Maturities Municipal Fund (NYSE:NIM) Stock Falls 0.6% - Should You Sell?2 hours agoHealth Catalyst (NASDAQ:HCAT) Stock Price Down 2.9% - Should You Sell?MarketBeatNASDAQ:HCATRead Health Catalyst (NASDAQ:HCAT) Stock Price Down 2.9% - Should You Sell?2 hours agoDouYu International (NASDAQ:DOYU) Stock Price Up 1.7% - Here's What HappenedMarketBeatNASDAQ:DOYURead DouYu International (NASDAQ:DOYU) Stock Price Up 1.7% - Here's What Happened2 hours agoOrganogenesis (NASDAQ:ORGO) Shares Down 3.6% - What's Next?MarketBeatNASDAQ:ORGORead Organogenesis (NASDAQ:ORGO) Shares Down 3.6% - What's Next?2 hours agoBausch Health Companies (TSE:BHC) Shares Down 0.7% - Here's WhyMarketBeatTSE:BHCRead Bausch Health Companies (TSE:BHC) Shares Down 0.7% - Here's Why2 hours agoBk Technologies (NYSEAMERICAN:BKTI) Shares Down 0.3% - Here's What HappenedMarketBeatNYSEAMERICAN:BKTIRead Bk Technologies (NYSEAMERICAN:BKTI) Shares Down 0.3% - Here's What Happened2 hours agoEnergean (LON:ENOG) Shares Up 2.2% - What's Next?MarketBeatLON:ENOGRead Energean (LON:ENOG) Shares Up 2.2% - What's Next?2 hours agoFirst Trust Small Cap Core AlphaDEX Fund (NASDAQ:FYX) Stock Price Down 0.2% - Should You Sell?MarketBeatNASDAQ:FYXRead First Trust Small Cap Core AlphaDEX Fund (NASDAQ:FYX) Stock Price Down 0.2% - Should You Sell?2 hours agoAmpliTech Group (NASDAQ:AMPG) Stock Price Down 3% - Here's WhyMarketBeatNASDAQ:AMPGRead AmpliTech Group (NASDAQ:AMPG) Stock Price Down 3% - Here's Why2 hours agoOakley Capital Investments (LON:OCI) Stock Jumps 1.4% - Here's WhyMarketBeatLON:OCIRead Oakley Capital Investments (LON:OCI) Stock Jumps 1.4% - Here's Why2 hours agoJamieson Wellness (TSE:JWEL) Shares Down 0.1% - What's Next?MarketBeatTSE:JWELRead Jamieson Wellness (TSE:JWEL) Shares Down 0.1% - What's Next?2 hours agoRadiant Logistics (NYSEAMERICAN:RLGT) Shares Up 0.2% - Still a Buy?MarketBeatNYSEAMERICAN:RLGTRead Radiant Logistics (NYSEAMERICAN:RLGT) Shares Up 0.2% - Still a Buy?2 hours agoBayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Down 0.8% - Here's WhyMarketBeatOTCMKTS:BAYRYRead Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Down 0.8% - Here's Why2 hours agoKits Eyecare Eyes Glasses-Led Growth as Margins Expand and Capacity RampsMarketBeatTSE:KITSRead Kits Eyecare Eyes Glasses-Led Growth as Margins Expand and Capacity Ramps3 hours agoStrategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) Shares Will Pay Dividend of $0.04MarketBeatNASDAQ:STRCRead Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) Shares Will Pay Dividend of $0.043 hours agoVertex Highlights Kidney Pipeline as Povetacicept Cuts Proteinuria 52% in Phase IIIMarketBeatNASDAQ:VRTXRead Vertex Highlights Kidney Pipeline as Povetacicept Cuts Proteinuria 52% in Phase III4 hours agoShare Repurchase Program Authorized by Vylor (NYSE:VYLR) Board of DirectorsMarketBeatNYSE:VYLRRead Share Repurchase Program Authorized by Vylor (NYSE:VYLR) Board of Directors4 hours agoNovartis Remibrutinib Cuts MS Relapses in Phase III, Eyes $4B OpportunityMarketBeatNYSE:NVSRead Novartis Remibrutinib Cuts MS Relapses in Phase III, Eyes $4B Opportunity5 hours agoVinci Compass Investments (NASDAQ:VINP) Insider Sells $32,181.84 in StockMarketBeatNASDAQ:VINPRead Vinci Compass Investments (NASDAQ:VINP) Insider Sells $32,181.84 in Stock5 hours agoVinci Compass Investments (NASDAQ:VINP) Insider Bruno Augusto Sacchi Zaremba Sells 3,843 Shares of Company StockMarketBeatNASDAQ:VINPRead Vinci Compass Investments (NASDAQ:VINP) Insider Bruno Augusto Sacchi Zaremba Sells 3,843 Shares of Company Stock5 hours agoVinci Compass Investments (NASDAQ:VINP) Stock: Insider Fernando Lovisotto Sells 5,211 SharesMarketBeatNASDAQ:VINPRead Vinci Compass Investments (NASDAQ:VINP) Stock: Insider Fernando Lovisotto Sells 5,211 Shares5 hours agoZoom Communications (NASDAQ:ZM) Stock: Insider Santiago Subotovsky Sells 717 SharesMarketBeatNASDAQ:ZMRead Zoom Communications (NASDAQ:ZM) Stock: Insider Santiago Subotovsky Sells 717 Shares Featured Articles and OffersThese 3 Green Stocks Have a Growth Story That Goes Far Beyond WashingtonBy Chris Markoch | October 18, 2026Iran War Shock: What I Was Told In That Private MeetingFrom Banyan Hill Publishing (Ad)Tesla's Roadster Reveal Hints at 2 Much Bigger MovesBy Sam Quirke | October 19, 2026Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't OverBy Jeffrey Neal Johnson | October 20, 2026GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?By Ryan Hasson | October 21, 2026How options let you do more with less capitalFrom Base Camp Trading (Ad)Is Texas Instruments Setting Up for Its Next Big Breakout?By Thomas Hughes | October 22, 2026Does the AI Sell-Off Put Alphabet's Breakout in Doubt?By Ryan Hasson | October 17, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 365 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
